Pankti Reid
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 24
- Colorectal Cancer Treatments and Studies 10
- CAR-T cell therapy research 6
-
- Chronic Lymphocytic Leukemia Research 8
-
- Rheumatoid Arthritis Research and Therapies 5
-
- Immune Cell Function and Interaction 4
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 4
- Co-authors
- Anne R. BassAdam S. CifuKammi HenriksenLaura C. CappelliAlexander J. GallanAnthony ChangDavid LiewNilasha Ghosh
- Cited by
- OncologyGeneticsRheumatology
- Partner nations
- United StatesAustraliaEgypt
In The Last Decade
Pankti Reid
38 papers receiving 355 citations
Peers
Comparison fields: 5 of 59
- Oncology 233
- Genetics 54
- Rheumatology 48
- Immunology 60
- Hematology 30
Countries citing papers authored by Pankti Reid
This map shows the geographic impact of Pankti Reid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pankti Reid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pankti Reid more than expected).
Fields of papers citing papers by Pankti Reid
This network shows the impact of papers produced by Pankti Reid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pankti Reid. The network helps show where Pankti Reid may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pankti Reid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 39 | |
| 10 | 2023 | 29 | |
| 11 | 2023 | 11 | |
| 12 | 2023 | 12 | |
| 13 | 2023 | 12 | |
| 14 | 2023 | 1 | |
| 15 | 2023 | 4 | |
| 16 | 2021 | 9 | |
| 17 | 2021 | 4 | |
| 18 | Treatment with tocilizumab does not inhibit induction of anti-COVID-19 antibodies in patients with severe SARS-CoV-2 infection | 2020 | 0 |
| 19 | 2018 | 9 | |
| 20 | Honey and angiogenesis | 2006 | 0 |
About Pankti Reid
Pankti Reid is a scholar working on Oncology, Genetics and Rheumatology, having authored 42 papers that have together received 358 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Colorectal Cancer Treatments and Studies (10 papers), Chronic Lymphocytic Leukemia Research (8 papers), CAR-T cell therapy research (6 papers), Rheumatoid Arthritis Research and Therapies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Oncology (233 citations), Genetics (54 citations) and Rheumatology (48 citations). Pankti Reid has collaborated with scholars based in United States, Australia and Egypt. Frequent co-authors include Anne R. Bass, Adam S. Cifu, Kammi Henriksen, Laura C. Cappelli, Alexander J. Gallan, Anthony Chang, David Liew, Nilasha Ghosh, Philip C. Robinson and Karmela K Chan.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.